Clinical Trial Update: Transdermal Versus Oral Oxybutynin in Pediatric OAB [NA]

View source ↗

Summary

The study comparing transdermal and oral oxybutynin in pediatric overactive bladder has completed; no results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Oxybutynin (oral) (oxybutynin)
• Oxybutynin transdermal (oxybutynin)

Snippet

Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital | Conditions: Overactive Bladder (OAB), Drug Delivery Systems | NA | Status: COMPLETED